Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;119:1203-1210
Published online before print February 23, 2009, doi: 10.1161/CIRCULATIONAHA.108.825364
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
119/9/1203    most recent
CIRCULATIONAHA.108.825364v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parikh, N. I.
Right arrow Articles by Levy, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parikh, N. I.
Right arrow Articles by Levy, D.
Related Collections
Right arrow Other diagnostic testing
Right arrow Acute myocardial infarction
Right arrow Epidemiology
Right arrowRelated Article

(Circulation. 2009;119:1203-1210.)
© 2009 American Heart Association, Inc.


Epidemiology

Long-Term Trends in Myocardial Infarction Incidence and Case Fatality in the National Heart, Lung, and Blood Institute’s Framingham Heart Study

Nisha I. Parikh, MD, MPH; Philimon Gona, PhD; Martin G. Larson, ScD; Caroline S. Fox, MD, MPH; Emelia J. Benjamin, MD, ScM; Joanne M. Murabito, MD, ScM; Christopher J. O'Donnell, MD, MPH; Ramachandran S. Vasan, MD; Daniel Levy, MD

From the National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, Mass (N.I.P., P.G., M.G.L., C.S.F., E.J.B., J.M., C.J.O., R.S.V., D.L.); Beth Israel Deaconess Medical Center, Cardiovascular Division, Boston, Mass (N.I.P.); Boston University, Boston, Mass (N.I.P., P.G., M.G.L.); Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.S.F.); Cardiology, Section of General Internal Medicine and Preventive Medicine Sections, Boston University School of Medicine, Boston, Mass (E.J.B., J.M., R.S.V., D.L.); Division of Cardiology, Massachusetts General Hospital, Boston (C.J.O.); and Center for Population Studies of the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (C.J.O., C.S.F., D.L.).

Correspondence to Daniel Levy, MD, Framingham Heart Study, 73 Mount Wayte Ave, Suite 2, Framingham, MA 01702–5803. E-mail levyd{at}nih.gov

Received September 30, 2008; accepted December 18, 2008.

Background— Whereas the prevalence of coronary heart disease risk factors has declined over the past decades in the United States, acute myocardial infarction (AMI) rates have been steady. We hypothesized that this paradox is due partly to the advent of increasingly sensitive biomarkers for AMI diagnosis.

Methods and Results— In Framingham Heart Study participants over 4 decades, we compared the incidence and survival rates of initial AMI diagnosis by ECG (AMI-ECG) regardless of biomarkers with those based exclusively on infarction biomarkers (AMI-marker). We used Poisson regression to calculate annual incidence rates of first AMI over 4 decades (1960 to 1969, 1970 to 1979, 1980 to 1989, and 1990 to 1999) and compared rates of AMI-ECG with rates of AMI-marker. Cox proportional-hazards analysis was used to compare AMI case fatality over 4 decades. In 9824 persons (54% women; follow-up, 212 539 person-years; age, 40 to 89 years), 941 AMIs occurred, including 639 AMI-ECG and 302 AMI-marker events. From 1960 to 1999, rates of AMI-ECG declined by {approx}50% and rates of AMI-marker increased {approx}2-fold. Crude 30-day, 1-year, and 5-year case fatality rates in 1960 to 1969 and 1990 to 1999 were 0.20 and 0.14, 0.24 and 0.21, and 0.45 and 0.41, respectively. Age- and sex-adjusted 30-day, 1-year, and 5-year AMI case fatality declined by 60% in 1960 to 1999 (P for trend <0.001), with parallel declines noted after AMI-ECG and AMI-marker.

Conclusions— Over the past 40 years, rates of AMI-ECG have declined by 50%, whereas rates of AMI-marker have doubled. Our findings offer an explanation for the apparently steady national AMI rates in the face of improvements in primary prevention.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 119: 1177-1179. [Extract] [Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
R. J. Goldberg
To the Framingham Data, Turn, Turn, Turn
Circulation, March 10, 2009; 119(9): 1189 - 1191.
[Full Text] [PDF]